Different breast cancer subtypes in women more than 65 years old
- سال انتشار: 1397
- محل انتشار: کنگره بین المللی جراحی سرطان شیراز
- کد COI اختصاصی: SISOC01_022
- زبان مقاله: انگلیسی
- تعداد مشاهده: 521
نویسندگان
Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
چکیده
Introduction: Breast cancer is the most common malignancy of females. Breast cancer is a heterogenic disease; it consists of several subtypes based on expression of different genes. risk factors associated with each subtype is not completely understood yet. Moreover, recognizing the cancer subtype may alter the treatment plan. The aim of this study was to evaluate different breast cancer subtypes in women more than 65 years old. Methods: This was a cross-sectional study done on breast cancer patients aged 65 years and older presenting to clinics of Emam Reza and Omid Hospitals, Mashhad, Iran between 2005 and 2015. Statistical analysis was carried out using SPSS ver. 16. P< 0.05 was considered statistically significant. Results: A total of 225 breast cancer patients age 65 and older were included in our study. When we categorized our patients by breast cancer subtypes 69.8% had the Luminal A, B subtype, 23.1% had Triple-Negative subtype and the remaining 7.1% had HER-2 enriched subtype. Conclusion: Different breast cancer subtypes in patients aged 65 years old and higher were Luminal A, B, HER-2 enriched and Triple-negative, respectively. We also showed that patients with Luminal A, B subtypes had significantly higher BMI and BSA compared to other subtypes.کلیدواژه ها
Breast cancer, Diagnosis, Age, Metastasisمقالات مرتبط جدید
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.